Value proposition

A drug-discovery company focused on oncology. Follow us on Twitter @OxDrugDes

Oxford Drug Design, an advanced spinout from Oxford University, is an innovative biotechnology company discovering and developing novel therapeutics supported by pioneering computational methods.

We design innovative drugs with differentiated modes of action against cancer and other challenging diseases with high unmet medical need seeking superior patient outcomes.

Based on the unique integration of our dual core competences in aminoacyl-tRNA synthetase enzymes and distinctive AI/ML methods, our pipeline expansion is focused on oncology. This distinctive drug discovery platform has been validated by the rapid discovery of novel therapeutic candidates with highly innovative chemical scaffolds and modes of action.

oncology therapeutics, anti-cancer drugs, tRNA synthetases, small molecules, drug design, drug discovery, virtual screening, ligand optimisation, lead optimisation, Histidine kinases, and machine learning